Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4HJO

Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib

Summary for 4HJO
Entry DOI10.2210/pdb4hjo/pdb
DescriptorEpidermal growth factor receptor, [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE (3 entities in total)
Functional Keywordsinactive tyrosine kinase domain, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (human)
Cellular locationCell membrane; Single-pass type I membrane protein. Isoform 2: Secreted: P00533
Total number of polymer chains1
Total formula weight38950.01
Authors
Park, J.H.,Lemmon, M.A. (deposition date: 2012-10-13, release date: 2012-11-14, Last modification date: 2023-09-20)
Primary citationPark, J.H.,Liu, Y.,Lemmon, M.A.,Radhakrishnan, R.
Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain.
Biochem.J., 448:417-423, 2012
Cited by
PubMed: 23101586
DOI: 10.1042/BJ20121513
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.75 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon